This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
12 results for: united kingdom
post featured image

MHRA announce new scheme for monitoring good manufacturing and distributions practices in IAG cases
By Taryn Jones, Teresa Hitchcock
The Medicines & Healthcare products Regulatory Agency (MHRA) has announced a new supervisory scheme as part of its process for monitoring...
post featured image

UK ABPI calls for standardised international approach to university-industry collaborations
By Richard Taylor, Anna Wrench
The Association of the British Pharmaceutical Industry (ABPI, the UK’s leading association for pharmaceutical companies), has published a...
post featured image

Clinical Trial Regulations in the EU – how will the UK follow?
By Kate Burgess
The European Medicines Agency has confirmed that the new Clinical Trials Regulation is now in effect as of 31 January 2022. Please see...
post featured image

Do medical devices have systematic bias?
By Kate Burgess, Anna Ward
An investigation has been launched by the UK’s Department of Health and Social Care (“DHSC”) with the overall aim of improving healthcare...
post featured image

Assessing the value of medicine for diverse patients: Implications of a QALY approach for health disparities
By Kirsten Axelsen
Momentum and debate about the application of cost-effectiveness analysis to determine the value and prices of prescription drugs in the...
post featured image

Open consultation on the future regulation of medical devices in the United Kingdom
By Richard Taylor, Elinor Cavil
BackgroundThe Medicines & Healthcare products Regulatory Agency (MHRA) is holding an open consultation to gather views on possible...
post featured image

The future regulation of medical devices in the UK under the Medicines and Medical Devices Act 2021
By Kate Burgess, Anna Ward
The Medicines and Medical Devices Act 2021 (the “MMD Act”) was granted royal assent on 11th February 2021. The MMD Act confers broad...
post featured image

Brexit and the MRDCRP - update on 5-digit company number
By Veronika Appl
On 23 February 2021, an update was published to the British Medicines and Healthcare products Regulatory Agency's (MHRA) Guidance on the...
post featured image

Telehealth - a white hot M&A market?
By Moritz von Hesberg
The global outlook for M&A in the digital health and particularly the telehealth sector has never been brighter than today. Telehealth’s...
post featured image

UK investment in life sciences
By Victoria Rhodes
At a time when the importance of the life sciences industry to our daily lives has never been clearer, the UK Government has been...
post featured image

Proposed Reform to the UK's NHS Procurement Regime
By Hannah Gardiner
On 11 February 2021, the Department of Health and Social Care published a white paper - Integration and innovation: working together to...
post featured image

Doctrine of equivalents: what's new in Continental Europe?
By Roberto Valenti
For the first time, in Eli Lilly v Actavis the UK Supreme Court has introduced a doctrine of equivalence in an effort to move closer to...